The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162)
Fluorodeoxyglucose F18 has been studied across 17 research domains including 🔥 Metabolic, 🔬 Oncology, ⏳ Longevity & Aging, 🧠 Neuroprotection, 🧬 Hormones. The primary research focus is 🔥 Metabolic with 66% of studies addressing this area.
This evidence profile for Fluorodeoxyglucose F18 is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.